Literature DB >> 20837497

Haematopoietic stem and progenitor cells in rheumatoid arthritis.

Inés Colmegna1, Cornelia M Weyand.   

Abstract

RA is the prototypic chronic inflammatory disease, characterized by progressive articular cartilage and bone destruction. The systemic nature of RA is evidenced by the increased risk of atherosclerosis and lymphoproliferative disorders. Components of both the innate and adaptive immune system are implicated in the pathophysiology of the articular and extra-articular manifestations of the disease. A fundamental process in the onset of RA is the breakdown in self-tolerance. Accelerated ageing of immune cells (immunosenescence) appears to be a major mechanism favouring the disruption of tolerance. Telomere erosion, a hallmark of immunosenescence, is present in lymphoid (naïve and memory T cells) and myeloid (granulocytes) cells in RA. The premature ageing process also involves the haematopoietic stem and progenitor cells (CD34(+) HSPC), thus extending the RA immunopathogenesis to include early events in the shaping of the immune system. This review summarizes current concepts of HSPC ageing and its impact on immune regeneration, highlighting the phenotypic and functional similarities between elderly and RA HSPC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20837497      PMCID: PMC3021951          DOI: 10.1093/rheumatology/keq298

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  79 in total

1.  Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages.

Authors:  Stefan O Schönland; Consuelo Lopez; Thomas Widmann; Julia Zimmer; Ewa Bryl; Jörg J Goronzy; Cornelia M Weyand
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-24       Impact factor: 11.205

Review 2.  When cells get stressed: an integrative view of cellular senescence.

Authors:  Ittai Ben-Porath; Robert A Weinberg
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

Review 3.  Telomeres in T and B cells.

Authors:  Richard J Hodes; Karen S Hathcock; Nan-ping Weng
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

Review 4.  Replicative senescence of hematopoietic stem cells during serial transplantation: does telomere shortening play a role?

Authors:  Richard C Allsopp; Irving L Weissman
Journal:  Oncogene       Date:  2002-05-13       Impact factor: 9.867

5.  Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age.

Authors:  C Kollman; C W Howe; C Anasetti; J H Antin; S M Davies; A H Filipovich; J Hegland; N Kamani; N A Kernan; R King; V Ratanatharathorn; D Weisdorf; D L Confer
Journal:  Blood       Date:  2001-10-01       Impact factor: 22.113

6.  Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation.

Authors:  Richard C Allsopp; Gregg B Morin; Ronald DePinho; Calvin B Harley; Irving L Weissman
Journal:  Blood       Date:  2003-03-27       Impact factor: 22.113

7.  Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect.

Authors:  Helen A Papadaki; Heraklis D Kritikos; Claudia Gemetzi; Helen Koutala; Judith C W Marsh; Dimitrios T Boumpas; George D Eliopoulos
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

8.  Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program.

Authors:  Hugo Castro-Malaspina; Richard E Harris; James Gajewski; Norma Ramsay; Robert Collins; Bernie Dharan; Roberta King; H Joachim Deeg
Journal:  Blood       Date:  2002-03-15       Impact factor: 22.113

9.  Telomere shortening accompanies increased cell cycle activity during serial transplantation of hematopoietic stem cells.

Authors:  R C Allsopp; S Cheshier; I L Weissman
Journal:  J Exp Med       Date:  2001-04-16       Impact factor: 14.307

10.  Age-associated characteristics of murine hematopoietic stem cells.

Authors:  K Sudo; H Ema; Y Morita; H Nakauchi
Journal:  J Exp Med       Date:  2000-11-06       Impact factor: 14.307

View more
  10 in total

Review 1.  Targets of immune regeneration in rheumatoid arthritis.

Authors:  Philipp J Hohensinner; Jörg J Goronzy; Cornelia M Weyand
Journal:  Mayo Clin Proc       Date:  2014-04       Impact factor: 7.616

Review 2.  T-cell aging in rheumatoid arthritis.

Authors:  Cornelia M Weyand; Zhen Yang; Jörg J Goronzy
Journal:  Curr Opin Rheumatol       Date:  2014-01       Impact factor: 5.006

3.  Preparation of Proper Immunogen by Cloning and Stable Expression of cDNA coding for Human Hematopoietic Stem Cell Marker CD34 in NIH-3T3 Mouse Fibroblast Cell Line.

Authors:  Farzaneh Shafaghat; Hajar Abbasi-Kenarsari; Jafar Majidi; Ali Akbar Movassaghpour; Dariush Shanehbandi; Tohid Kazemi
Journal:  Adv Pharm Bull       Date:  2015-03-05

4.  Telomere dysfunction-related serological markers and oxidative stress markers in rheumatoid arthritis patients: correlation with diseases activity.

Authors:  Rania M Gamal; Nevin Hammam; Madeha M Zakary; Marwa Mahmoud Abdelaziz; Mohamed Raouf Abdel Razek; Mona Sallam Embarek Mohamed; Yaser Emad; Mohamed Galal Elnaggar; Daniel E Furst
Journal:  Clin Rheumatol       Date:  2018-10-16       Impact factor: 2.980

Review 5.  Hematopoietic stem cell transplantation for systemic lupus erythematosus.

Authors:  Alberto M Marmont du Haut Champ
Journal:  Clin Dev Immunol       Date:  2012-08-30

6.  Reactivity of rat bone marrow-derived macrophages to neurotransmitter stimulation in the context of collagen II-induced arthritis.

Authors:  Dominique Muschter; Claudia Göttl; Mandy Vogel; Joachim Grifka; Rainer H Straub; Susanne Grässel
Journal:  Arthritis Res Ther       Date:  2015-06-24       Impact factor: 5.156

7.  Uniquely human CHRFAM7A gene increases the hematopoietic stem cell reservoir in mice and amplifies their inflammatory response.

Authors:  Todd W Costantini; Theresa W Chan; Olga Cohen; Simone Langness; Sabrina Treadwell; Elliot Williams; Brian P Eliceiri; Andrew Baird
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-03       Impact factor: 11.205

8.  Pro-inflammatory cytokine blockade attenuates myeloid expansion in a murine model of rheumatoid arthritis.

Authors:  Giovanny Hernandez; Taylor S Mills; Jennifer L Rabe; James S Chavez; Susan Kuldanek; Gregory Kirkpatrick; Leila Noetzli; Widian K Jubair; Michelle Zanche; Jason R Myers; Brett M Stevens; Courtney J Fleenor; Biniam Adane; Charles A Dinarello; John Ashton; Craig T Jordan; Jorge Di Paola; James R Hagman; V Michael Holers; Kristine A Kuhn; Eric M Pietras
Journal:  Haematologica       Date:  2019-05-17       Impact factor: 9.941

Review 9.  Molecular Mechanisms of Immunosenescene and Inflammaging: Relevance to the Immunopathogenesis and Treatment of Multiple Sclerosis.

Authors:  Océane Perdaens; Vincent van Pesch
Journal:  Front Neurol       Date:  2022-02-25       Impact factor: 4.003

Review 10.  Inflammation as a regulator of hematopoietic stem cell function in disease, aging, and clonal selection.

Authors:  Eric M Pietras; Markus G Manz; Francisco Caiado
Journal:  J Exp Med       Date:  2021-06-15       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.